亚抑菌浓度亚胺培南对多重耐药鲍曼不动杆菌生物膜作用的研究

中国药物评价 ›› 2021, Vol. 38 ›› Issue (3): 224-228.

亚抑菌浓度亚胺培南对多重耐药鲍曼不动杆菌生物膜作用的研究

方甜甜1，宋沧桑1，刘德华2，唐树荣2，徐磊3，李兴德1，杨焕芝1，丁逸欣4，任宝军2*

1. 昆明市第一人民医院药学部，云南昆明 650031；
2. 昆明市第一人民医院检验科，云南昆明 650031；
3. 大理大学，云南大理 671000；
4. 昆明医科大学，云南昆明 650500

收稿日期:2021-02-01 修回日期:2021-04-29 出版日期:2021-06-28 发布日期:2021-06-28
基金资助:
昆明市科技局项目（No. 2019KJJH073）；云南省教育厅科学研究基金项目（No. 2019J1295）；昆明市卫生科技人才培养项目[项2020-SW（后备）-36]

Study on the Effect of Imipenem at Subinhibitory Concentration for the Biofilm of Multi-drug Resistant Acinetobacter Baumannii

1. Department of Pharmacy， Kuming Municipal First People′s Hospital， Yunnan Kunming 650031， China；
2. Clinical Laboratory Kunming First People′s Hospital， Yunnan Kunming 650031，China；
3. Dali University， Yunnan Dali 671000， China；
4. Kuming Medical University，Yunnan Kunming 650500， China

Received:2021-02-01 Revised:2021-04-29 Online:2021-06-28 Published:2021-06-28
Contact: ren baojun E-mail:158671358@qq.com

摘要/Abstract

摘要： 目的：探讨亚抑菌浓度亚胺培南对多重耐药鲍曼不动杆菌生物膜的影响。方法：采用微量肉汤稀释法，测定医院2019年2月至2020年9月临床分离的36株亚胺培南耐药多重耐药鲍曼不动杆菌（MDR-AB）的最低抑菌浓度（MIC），结晶紫半定量染色法测定菌株生物膜形成水平。采用96孔聚苯乙烯板体外构建鲍曼不动杆菌生物膜的模型，用亚抑菌浓度亚胺培南作用于成熟生物膜。实验组Ⅰ、Ⅱ、Ⅲ组中分别用MIC、1/2MIC、1/4MIC的亚胺培南作用于已形成的成熟生物膜；对照组Ⅳ组不加亚胺培南。通过结晶紫半定量染色法对生物膜进行染色，共聚焦倒置显微镜下观察生物膜染色情况，采用多功能酶标仪在570 nm波长处测得生物膜OD值。结果：亚胺培南在实验组Ⅰ、Ⅱ、Ⅲ组中，即 MIC、1/2MIC、1/4MIC 浓度下作用于已成熟生物膜 48、96 h后，所测得OD值与对照组 Ⅳ组OD值之间进行比较，有显著性差异（P＜0.05)。结论：亚抑菌浓度亚胺培南具有破坏成熟生物膜的能力，且随着浓度的升高，其破坏能力更强。

关键词: font-size:13.3333px, ">多重耐药鲍曼不动杆菌；生物膜；亚抑菌浓度；亚胺培南

Abstract: Objective： To investigate the influnce of Imipenem in Sub-inhibitory concentration against the biofilm formation of Multiple drug resistant Acinetobacter Bauman (MDR-Ab). Methods： The minimum inhibitory concentration (MIC) of imipenem against 36 imipenem-resistant multidrug-resistant Acinetobacter baumannii (MDR-Ab) strains isolated from a third-class A hospital from February 2019 to September 2020 was determined by microbroth dilution method. The biofilm formation level of the strains was determined by semi-quantitative crystal purple method. The biofilm model of Acinetobacter baumannii was constructed by 96-well polystyrene plate in vitro. After the mature biofilm was formed， imipenem at subinhibitory concentration was applied to the mature biofilm. The mature biofilms in experimental groups Ⅰ，Ⅱ and Ⅲ were treated with imipenem of MIC， 1/2MIC and 1/4MIC， respectively. Control group Ⅳ did not receive imipenem. The biofilm was stained by crystalline violet semi-quantitative staining， and the biofilm staining was observed under a confocal inverted microscope. The OD value of the biofilm was measured at 570 nm by a multifunctional enzyme plate analyzer. Results： In experimental groups Ⅰ，Ⅱ and Ⅲ， i.e. MIC， 1/2MIC and 1/4MIC， imipenem was applied to the mature biofilm for 48h and 96h， the measured OD values were compared with the control group， and there were significant differences (P＜0.05). Conclusion： The subinhibitory concentration of imipenem has the ability to destroy mature biofilm， and the damage ability becomes stronger with the increase of the concentration.

Key words: font-size:13.3333px, ">Multidrug-resistant Acinetobacter baumannii； Biofilm； Subinhibitory concentration； Imipenem

中图分类号:

方甜甜, 宋沧桑, 刘德华, 唐树荣, 徐磊, 李兴德, 杨焕芝, 丁逸欣, 任宝军. 亚抑菌浓度亚胺培南对多重耐药鲍曼不动杆菌生物膜作用的研究[J]. 中国药物评价, 2021, 38(3): 224-228.

FANG Tian-tian, SONG Cang-sang, LIU De-hua, TANG Shu-rong, XU Lei, LI Xing-de, YANG Huan-zhi, DING Yi-xin, REN Bao-jun. Study on the Effect of Imipenem at Subinhibitory Concentration for the Biofilm of Multi-drug Resistant Acinetobacter Baumannii[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2021, 38(3): 224-228.

参考文献

[1]Song, JY; Cheong, HJ; Noh, JY, et al.In vitro Comparison of Anti-Biofilm Effects against Carbapenem-Resistant Acinetobacter baumannii: Imipenem,Colistin,Tigecycline,Rifampicin and Combinations[J].Infect Chemother, 2015, 47(1):27-32
[2]BABAPOUR E，HADDADI A，MIRNEJAD R，et al.Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance[J].Asian Pac J Trop Biomed, 2016, 6(6):528-533
[3]QI L，LI H，ZHANG C，et al．.Relationship between antibiotic resistance，biofilm formation，and biofilm-specific resistance in Acinetobacter baumannii[J].Front Microbiol, 2016, 7(无):1-10
[4]樊莉, 李聃丹, 田竞等.亚抑菌浓度亚胺培南通过影响Ⅳ型菌毛增强耐药鲍曼不动杆菌的生物膜形成[J].第三军医大学学报, 2018, 40(21):1967-1972
[5]尹珍，黄文祥，杨均均，等.耐碳青霉烯类鲍曼不动杆菌流行克隆株生物被膜形成能力分析[J].中国感染与化疗杂志, 2018, 18(2):184-189
[6]吕月贤，金玉芬，于庭.替加环素对鲍曼不动杆菌生物膜影响的研究[J].中国实验诊断学, 2017, 21(02):329-332
[7]MUＲAKAMI K，ONO T，NOMA Y，et al.Explorative gene analysis of antibiotic tolerance-related genes in adherent and biofilm cells of Pseudomonas aeruginosa[J].J Infect Chemother, 2017, 23(5):271-277
[8]FUＲUKAWA S.Studies on formation，control and applica- tion of biofilm formed by food related microorganisms[J].Biosci Biotechnol Biochem, 2015, 79(7):1050-1056
[9]KIM H A，ＲYU S Y，SEO I，et al.Biofilm formation and colistin susceptibility of acinetobacter baumannii isolated from korean nosocomial samples[J].Microb Drug Ｒesist, 2015, 21(4):452-457
[10]GＲEENE C，WU J，ＲICKAＲD A H，et al.Evaluation of the ability of Acinetobacter baumannii to form biofilms on six different biomedical relevant surfaces[J].Lett Appl Micro- biol, 2016, 63(4):233-239

[1]	李川, 杨军令, 程晨, 贾伟伟. 中药新药的药代研究[J]. 中国药物评价, 2023, 40(6): 457-459.
[2]	叶潇, 郑爽#, 林超, 黄舒佳, 王宇, 于敏, 刘颖. 生物分析方法验证及生物样品分析各指导原则间的比较[J]. 中国药物评价, 2023, 40(6): 470-479.
[3]	李丽, 刘婉如, 张征, 江志杰, 李宁. 逐瘀通脉胶囊对大鼠急性局灶性脑缺血再灌注损伤的影响[J]. 中国药物评价, 2023, 40(6): 502-505.
[4]	颜若曦. 《PIC/S生物技术检查备忘录》分析与探讨[J]. 中国药物评价, 2023, 40(6): 537-540.
[5]	甘加明, 邹瑜, 黄丹, 陈冬华, 严全鸿. 基于流池法的氨糖美辛肠溶片体外溶出行为研究[J]. 中国药物评价, 2023, 40(6): 480-484.
[6]	徐桂连, 董斌, 韩春晖, 郝爱鱼. 磷酸苯丙哌林多晶型制备、表征及平衡溶解度研究[J]. 中国药物评价, 2023, 40(6): 489-493.
[7]	代琪, 李康曦, 叶俏波, 文永盛, 许莉, 李及. 僵蚕化学成分、药理作用及毒理学研究进展[J]. 中国药物评价, 2023, 40(5): 402-408.
[8]	赵磊, 杨铭, 王皓, 马彧, 马金刚, 姜大成, 王路宏, 昝珂. 沙棘不同采收期与不同干燥过程真菌毒素的考察及其风险评估[J]. 中国药物评价, 2023, 40(5): 377-383.
[9]	洪淑华, 林琪珊, 柴将红, 潘红炬. 佐匹克隆有关物质及其校正因子影响因素的测定研究[J]. 中国药物评价, 2023, 40(5): 384-388.
[10]	李悦忱, 崔韶婧, 赵月然. 高效液相色谱-柱后光化学衍生法测定活血止痛胶囊中黄曲霉毒素的含量[J]. 中国药物评价, 2023, 40(5): 390-395.
[11]	田洁, 郝爱鱼, 鹿麟, 邹翩, 董斌. 几种药物配伍对常见塑料包装输液产品中不溶性微粒的影响研究[J]. 中国药物评价, 2023, 40(5): 396-401.
[12]	杨艳青, 陈春梅, 陈伟, 吴瑞, 王学昌, 段莲. 信迪利单抗一线治疗晚期非小细胞肺癌的快速卫生技术评估[J]. 中国药物评价, 2023, 40(5): 409-415.
[13]	江依帆, 陈丽萍, 张若钰, 巫培豪, 邱嘉珉, 宣建伟, 毕惠嫦. 抑酸药物的临床综合评价指标体系构建[J]. 中国药物评价, 2023, 40(5): 416-421.
[14]	华敏凡, 宋沧桑, 李兴德, 陆维, 毛盼盼, 王国徽. 服药依从性预测模型临床应用研究进展[J]. 中国药物评价, 2023, 40(5): 422-425.
[15]	黄波, 曹晓明. 等渗与低渗造影剂对老年肾功能损伤患者行冠脉造影术的安全性临床观察[J]. 中国药物评价, 2023, 40(5): 426-429.